Filter Results:
(5,261)
Show Results For
- All HBS Web
(5,261)
- People (20)
- News (2,086)
- Research (2,520)
- Events (2)
- Multimedia (224)
- Faculty Publications (1,976)
Show Results For
- All HBS Web
(5,261)
- People (20)
- News (2,086)
- Research (2,520)
- Events (2)
- Multimedia (224)
- Faculty Publications (1,976)
- 26 May 2020
- News
The Five Deadly Sins Of Private Health Insurance
- 13 Dec 2006
- Research & Ideas
Improving Public Health for the Poor
School of Public Health, Project Antares aims to create a system for devising commercial incentives that provide affordable public health initiatives, or "interventions" in healthcare parlance. Examples of commercial high-impact... View Details
- 14 Nov 2019
- Video
Health Minute: Measure Costs Correctly for Better Patient Outcomes
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)
- April 18, 2022
- Article
Will mRNA Technology Companies Spawn Innovation Ecosystems?
By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
The mRNA technologies that helped rapidly create effective COVID-19 vaccines could become technology platform businesses, which has tremendous implications for players in the world of drug development. These platforms could attract other companies interested in... View Details
Keywords: Health Care; Digital Health; Technology; Innovation; Health Care and Treatment; Technological Innovation; Digital Transformation; Health Industry; United States
Grimpe, Christoph, Timo Minssen, W. Nicholson Price, II, and Ariel Dora Stern. "Will mRNA Technology Companies Spawn Innovation Ecosystems?" Harvard Business Review (website) (April 18, 2022).
- 23 May 2023
- Cold Call Podcast
The Entrepreneurial Journey of China’s First Private Mental Health Hospital
- January 2014
- Teaching Note
Dr. Benjamin Hooks and Children's Health Forum
By: Rosabeth Moss Kanter and Ai-Ling Malone
The case includes law, business, and public health perspectives on an African American leader's social entrepreneurship and leadership in other social movements. Later in his life, Dr. Benjamin Hooks championed the eradication of lead poisoning. Prior to that Hooks... View Details
- 22 Apr 2009
- Other Presentation
Redefining Global Health Care: Narrowing the Gap Between Aspiration and Action
By: Michael E. Porter and Jim Yong Kim
Gaps in health financing, human resources, and access to care have fatal consequences for millions in developing countries. View Details
Porter, Michael E., and Jim Yong Kim. "Redefining Global Health Care: Narrowing the Gap Between Aspiration and Action." Global Health Delivery Case Discussion, Global Health Delivery Project at Harvard University, Boston, MA, April 22, 2009.
- August 2013 (Revised August 2014)
- Case
Aon Hewitt's Private Health Insurance Exchange
By: Regina E. Herzlinger, Aiden Y. Feng and Meghan D. Oliver
Aon Hewitt, a leading health insurance broker and consultant, is one of the first movers in forming exchanges to sell health insurance. What kinds of products should it offer on this exchange? View Details
- 28 Apr 2016
- News
Is good health good for business?
- Article
Private Enterprise for Public Health
By: Michael Chu and David E. Bloom
By many measures, the world today is a healthier place than ever before, yet a daunting set of deficits and disparities remains to be tackled. For various reasons, it is not clear that the traditional tandem of government and civil society are up to those challenges.... View Details
Keywords: Private Ownership; Social Enterprise; Public Sector; Private Sector; Health Care and Treatment; Health Industry
Chu, Michael, and David E. Bloom. "Private Enterprise for Public Health." Global Investor (Credit Suisse) (February 2012), 14–16.
- Article
Time-Driven Activity-Based Costing in Breast Cancer Care Delivery
By: Navraj S. Nagra, Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley and Andrea L. Pusic
We used time-driven activity-based costing (TDABC) to calculate the complete cost of breast cancer care—initial treatment planning, chemotherapy, radiation therapy, surgical resection and reconstruction, and ancillary services (psychosocial oncology, physical therapy.... View Details
Nagra, Navraj S., Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley, and Andrea L. Pusic. "Time-Driven Activity-Based Costing in Breast Cancer Care Delivery." Annals of Surgical Oncology 29, no. 1 (January 2022): 510–521.
- 24 Jun 2016
- News
Health insurance mergers put consumers last
Give Employees Cash to Purchase Their Own Health Insurance
Employers’ and employees’ health care costs continue to skyrocket. A solution is to allow employers to give employees pre-tax cash to purchase their own health insurance. This move, enabled by a newly enacted federal rule, would put competitive pressure on insurers,... View Details
- August 2022 (Revised January 2023)
- Case
Icario Health: AI to Drive Health Engagement
By: David C. Edelman
Icario Health has built a market-leading artificial intelligence (AI) engine to help health insurers drive better health behaviors for their members, enabling the insurers to improve their Medicare performance. View Details
Keywords: Marketing; Health Care and Treatment; AI and Machine Learning; Health Industry; United States
Edelman, David C. "Icario Health: AI to Drive Health Engagement." Harvard Business School Case 523-025, August 2022. (Revised January 2023.)
- Web
Health Policy (Management) - Doctoral
Health Policy (Management) Health care is one of the most complex and fiercely debated industries in the country, and the ramifications of policy decisions reverberate through... View Details
- August 2014
- Case
Blue Cross Blue Shield of Florida, Inc.
By: Regina E. Herzlinger and Meng Li
Keywords: Health; Health Care Industry; Health Insurance; United States; Health Care and Treatment; Health Industry; United States; Florida
Herzlinger, Regina E., and Meng Li. "Blue Cross Blue Shield of Florida, Inc." Harvard Business School Case 315-009, August 2014.
- 20 Jul 2020
- Op-Ed
It's Time for a Bipartisan Health Plan for Employers and Employees
HRA-Public Option combination, employers that are now compelled to continually raise out-of-pocket expenses to employees to control health care costs will no longer be caught in the middle between the... View Details
- September 2019
- Technical Note
Care Economy in the U.S. (Primer)
By: Joseph B. Fuller, William R. Kerr, Manjari Raman and Carl Kreitzberg
This case describes how caregiving responsibilities influence American employees, firms, and the broader economy. It details how sociodemographic trends in the late 20th century transformed the way that Americans balance their personal and professional lives, analyzing... View Details
Keywords: Human Resources; Talent and Talent Management; Demographics; Labor; Health Care and Treatment; Family and Family Relationships; Strategy; Management; United States
Fuller, Joseph B., William R. Kerr, Manjari Raman, and Carl Kreitzberg. "Care Economy in the U.S. (Primer)." Harvard Business School Technical Note 820-027, September 2019.
- April 15, 2020
- Other Article
Designating Certain Post-Acute Care Facilities As COVID-19 Skilled Care Centers Can Increase Hospital Capacity And Keep Nursing Home Patients Safer
By: Leemore S. Dafny and Steven S. Lee
As the number of COVID-19 cases nationwide continues to grow, many hospitals will need to convert acute care beds into intensive care beds and discharge stable patients to post-acute care settings such as nursing homes. In addition, nursing homes unable to care for... View Details
Dafny, Leemore S., and Steven S. Lee. "Designating Certain Post-Acute Care Facilities As COVID-19 Skilled Care Centers Can Increase Hospital Capacity And Keep Nursing Home Patients Safer." Health Affairs Blog (April 15, 2020).